Board of Directors

Internal Board

Kumsal Bayazit

Kumsal Bayazit was appointed Chief Executive Officer of Elsevier in February 2019. She has held multiple positions with RELX Group since 2004, most recently as Regional President Europe, Middle East and Africa at Reed Exhibitions. Before joining Reed Exhibitions in 2016, Kumsal was RELX Group’s Chief Strategy Officer, responsible for driving strategic initiatives, technology strategy and portfolio management. Prior to that she served in several operational and strategic roles with LexisNexis.
Kumsal also chairs the Technology Forum at RELX Group and is a non-executive director at LSL Property Services plc. Prior to joining RELX Group in 2004, Kumsal spent several years at Bain & Company in their New York, Los Angeles, Johannesburg and Sydney offices.

Márcia Balisciano

Márcia is founding director of corporate responsibility at RELX, the information, analytics and events company with 33,000+ people and operations in 40 countries. Working with colleagues throughout the business, she drives practice ensuring recognition for RELX as a CR leader. Over the last year, RELX scored 1st for ESG in the media and publishing sectors (and 17th overall) among 12,000+ companies assessed by Sustainalytics and was one of 36 LEAD companies of the United Nations Global Compact among approximately 10,000 corporate signatories. She is responsible for the free RELX SDG Resource Centre featuring news, articles, tools, original research, events and more – from across RELX and key UN and other partners – to advance knowledge of the UN Sustainable Development Goals.

She is Chair of the UN Global Compact Network UK; Chair of the Corporate Responsibility and Sustainability Council of the Conference Board; and a member of the Board of the Ban Ki-moon Centre for Global Citizens. She is founding director of London museum and educational facility Benjamin Franklin House. A Fellow of the Royal Society of Arts, she holds an MA in International Relations from the University of Chicago, and a PHD in Economic History from the London School of Economics. She is a Member of the British Empire (MBE), an honour awarded by the Queen, and lives in London with her husband and two boys.

YoungSuk ‘YS’ Chi

YoungSuk ‘YS’ Chi is an international businessman and a leader in the media and technology industry, and currently serves Elsevier and RELX Group in several different capacities. In his primary role as head of Corporate Affairs for RELX Group, he is responsible for government affairs, corporate communications, corporate responsibility, and Asia strategy for Elsevier’s parent company. As non-executive Chairman of Elsevier, he works directly with governments, Elsevier customers and in industry associations worldwide. Mr. Chi also serves as President of the International Publishers Association, a global organization that represents the interests of more than 50 publishing industry association members from countries around the world. Early in his career, as Chief Operating Officer of Ingram Book Group, Mr. Chi founded Lightning Source, the first ever print-on-demand distributor and e-book services provider. After holding several senior executive positions at Ingram Book Group’s parent company, he became President and Chief Operating Officer of Random House. Mr. Chi has also earned widespread respect for his ability to work across cultures. As founding Chairman of Random House Asia, he led efforts to make Random House the first foreign trade book publisher with local language publishing in Japan and Korea. Mr. Chi has served on numerous charitable, educational and industry boards, including Princeton University, Korean American Community Foundation and McCarter Theatre. He is also a member of the Executive Committee of the boards of Association of American Publishers and International Association of Scientific, Technical & Medical Publishers.

esra erkal

Esra Erkal

Esra is a senior corporate affairs executive with a career that spans healthcare, consumer and regulatory sectors. She joined Elsevier in December 2019 from Coty, the global beauty company, where she was Chief Corporate Affairs Officer. Prior to that, Esra spent over seven years at AstraZeneca as the Global Head of Communications, leading the engagement with a wide range of stakeholders in the research, healthcare and investor ecosystem, including the development of the company’s community investment and sustainability strategy. Before joining AstraZeneca, Esra was an Executive Director of the Advertising Standards Authority in charge of Policy, Public Affairs and Communications, where she played a critical role in establishing internet regulation for the first time and transformed the way the watchdog works with industry and government to maintain responsible marketing standards. Previously, she was Head of Corporate Communications and External Affairs for the L’Oreal Group for seven years where she led the L’Oreal / UNESCO for Women in Science laureate programme. Prior to L’Oreal, Esra was Head of Corporate Affairs for Unilever. Esra is passionate about scientific progress and is a long-standing Trustee and Chairman of the British Skin Foundation, a charity dedicated to advancing research into skin cancer and skin health.

External Board

Yuko Harayama

Dr. Yuko Harayama is an Executive Director in charge of international affairs, the promotion of early career researchers and diversity at RIKEN, Japan’s largest research organization for basic and applied science. Prior to joining RIKEN in 2020, Dr. Harayama spent 5 years at the Cabinet Office of Japan serving as an Executive Member of the Council for Science and Technology Policy, Cabinet Office of Japan. She is the former Deputy Director of the Directorate for Science, Technology and Innovation, OECD. She is a Legion D’Honneur recipient (Chevalier), and was awarded honorary doctorate from the University of Neuchâtel. Previously, she was Professor in the Department of Management Science and Technology at the Graduate School of Engineering of Tohoku University. She holds a Ph.D. in education sciences and a Ph.D. in economics, both from the University of Geneva.

Nikunj Jinsi

Nikunj Jinsi has over 20 years of venture capital investment experience, in developing markets. Mr Jinsi currently advises several global finance institutions on developing their venture programs for emerging markets. In addition, Mr Jinsi is currently involved in founding multiple innovative investment platforms, each leveraging his unique investment background in developing markets.

Until mid-2019, Mr. Jinsi spent 16 years with the International Finance Corporation (IFC) where he built the largest EM focused venture platform, in terms of footprint coverage, and headed a team of over 30 investment professionals in eight locations globally. He has held board positions in several leading technology companies in Emerging Markets and been involved in 12 investments that have gone on to be unicorns. Mr Jinsi is currently the founding Chairman of EMPEA’s Venture Capital chapter. Prior to joining IFC in Washington DC, Mr. Jinsi spent nine years living and working in Asia. He was a Managing Director for one of Asia's leading venture funds. Earlier he spent four years in the Asian TMT investment banking industry providing M&A and corporate finance services to clients throughout the region. In addition, Mr Jinsi was the co-founder of South East Asia's largest independent marketing communications agency, which was successfully sold to the Omnicom Group. Mr. Jinsi started his career working as a Project Engineer/Manager at KPN, in The Hague, The Netherlands.

Mr Jinsi, a Dutch national, has an MBA degree from Stanford University, which he attended as a Fulbright Scholar, and an M Sc. degree in Electrical Engineering, from Delft University of
Technology, The Netherlands.

Beverly Malone

Dr. Beverly Malone is currently President and CEO of the National League for Nursing. Her tenure at the NLN has been marked by a retooling of the League's mission to reflect the core values of caring, diversity, integrity, and excellence and an ongoing focus on advancing the health of the nation and the global community. She was ranked amongst the 100 Most Influential People in Healthcare by Modern Healthcare magazine in 2010 and 2015; in 2016 Dr. Malone moved up the ladder to claim 39th place in the field of leading policy-makers, activists, health care professionals, and corporate figures in the health care, insurance, and pharmaceutical industries. Additional recognition in 2016 includes the Florence Nightingale Award and induction into the Home Care & Hospice Hall of Fame, an honorary doctorate from Georgetown University; and induction into the Nursing Hall of Fame at Tuskegee University in Alabama. Within the last several years, Dr. Malone was elected to the Institute of Medicine and tapped to join the board of the Kaiser Family Foundation.

Dr. Malone served on the Institute of Medicine's Forum on the Future of Nursing Education, contributing to the IOM's groundbreaking report, "The Future of Nursing: Leading Change, Advancing Health," and on the Advisory Committee on Minority Health, a federal panel established to advise the secretary of health and human services. Her distinguished career has mixed policy, education, administration, and clinical practice. Dr. Malone has worked as a surgical staff nurse, clinical nurse specialist, director of nursing, and assistant administrator of nursing. During the 1980s she was dean of the School of Nursing at North Carolina Agricultural and Technical State University. In 1996, she was elected to two terms as president of the American Nurses Association (ANA), representing 180,000 nurses in the USA. In 2000, she became deputy assistant secretary for health within the US Department of Health and Human Services, following four years of service on President Bill Clinton’s Advisory Commission on Consumer Protection and Quality in the Healthcare Industry. Just prior to joining the NLN, Dr. Malone was general secretary of the Royal College of Nursing (RCN), the United Kingdom's largest professional union of nurses, from June 2001 to January 2007. She also served between 2002 and 2006, as a member of the UK delegation to the World Health Assembly; of the Commonwealth Nurses Federation (CNF); and of the Higher Education Funding Council for England (HEFCE). During that time, Dr. Malone was also vice chair of the Brussels-based European Federation of Nurses Association (EFN).

Emilie Marcus

Emilie Marcus is the Executive Strategy Officer at the UCLA David Geffen School of Medicine where she is responsible for working with the leadership of the school and hospital system to drive alignment between medical and graduate school education, biomedical research and clinical care for optimized health outcomes. Prior to joining UCLA in 2018, Emilie spent 20 years at Cell Press with the last 7 years as CEO and the last 15 years as Editor-in-Chief of the journal Cell. Under her leadership, Cell Press expanded beyond biomedicine to become an all-science publisher, launching successful journals in chemistry and energy and the new interdisciplinary journal iScience. She also introduced industry-leading innovations in peer-review, methods reporting to support reproducibility and expediting access to early versions of articles that are under consideration for publication. As Editor-in-Chief of Cell, Emilie was responsible for setting the long-term strategy for the journal and assessing cutting-edge high-impact conceptual advances in biomedical research globally. She is often looked to as a thought leader on issues facing scientific publishing including the value and robustness of the peer-review process, handling potential conflicts, scientific ethics and misconduct, supporting rigor and reproducibility, the impact of new information technologies and new publishing business models, and the uses and abuses of the impact factor as a measure of quality. Prior to joining Cell Press, Emilie had a successful research career, first at Yale University, where she received her PhD in Biology/Neuroscience in 1993, and then at the Salk Institute and University of California at San Diego. Emilie was also Editor of Neuron from 2001 to 2003.

Geraldine Richmond

Prof. Geraldine Richmond is the Presidential Chair in Science and Professor of Chemistry at the University of Oregon. Her research has relevance to current issues in energy production, environmental remediation and atmospheric chemistry. Her teaching activities in the classroom and beyond focus on science literacy, science policy and building a strong and diverse science and engineering workforce in the U.S. and globally. Throughout her career she has been actively involved in efforts to increase the number and success of women in science and engineering. Richmond is a member of the National Academy of Sciences, the American Academy of Arts and Sciences and is a Fellow of the American Chemical Society (ACS), the American Physical Society (APS), the Association for the Advancement of Science (AAAS) and the Association for Women in Science. Richmond recently finished her term as President of AAAS and is currently the Chair of the Board of AAAS. She is also currently serving as a member of the National Science Board (President Obama appointee. She is the founding and current director of COACh (, a grass-roots organization formed in 1998 that has helped in the career advancement of thousands of scientists and engineers in the U.S., Asia, Africa and Latin America. She is also a member of the Elsevier Foundation ( Board which works to advance diversity in science, research in developing countries and technology for development.